Title of article
Adverse Drug Reactions of Multiple Sclerosis Disease-modifying Drugs
Author/Authors
Salehbayat ، Maryam School of Pharmacy - Tehran University of Medical Sciences, International Campus , Abolfazli ، Roya Department of Neurology - Amiralam Hospital - Tehran University of Medical Sciences , Mohebbi ، Niayesh Department of Clinical Pharmacy - Rational Use of Drugs Research Center, Faculty of Pharmacy - Tehran University of Medical Sciences , Savar ، Mehrdad Research Center for Rational Use of Drugs - Tehran University of Medical Sciences , Shalviri ، Gloria Research Center for Rational Use of Drugs - Tehran University of Medical Sciences , Gholami ، Kheirollah Department of Clinical Pharmacy - Rational Use of Drugs Research Center, Faculty of Pharmacy - Tehran University of Medical Sciences
From page
879
To page
884
Abstract
Introduction: High frequency of adverse drug reactions (ADRs) challenges multiple sclerosis (MS) treatment. This study aims to assess the nature and frequency of ADRs induced by MS medications in an observational cross-sectional study. Methods: ADRs of all outpatients who had seen a neurologist and had received at least one disease-modifying therapy (DMT) for MS during the last three months were investigated. Results: A total of 484 ADRs were detected in these patients. The preventability rate was 5.9%, and 0.61% of reactions were serious. Conclusion: The high frequency of adverse drug reactions in this study shows a strong need for strategy planning to increase patients’ adherence to treatment.
Keywords
Adverse drug reactions , Interferons , Neuropharmacology , Neurology , Compliance
Journal title
Basic and Clinical Neuroscience
Journal title
Basic and Clinical Neuroscience
Record number
2764224
Link To Document